Rockley Photonics and Medtronic have agreed to enter a partnership to develop the next generation of wearable healthcare monitoring devices.

The new collaboration is aimed at adding Rockley’s new Bioptx biomarker sensing platform to Medtronic’s solutions for use in several healthcare settings.

The Bioptx platform provides key insights for professional healthcare services.

It also provides an end-to-end sensing solution that integrates artificial intelligence (AI) and Cloud analytics to deliver a complete assessment of a variety of conditions.

Rockley has designed its biosensing technology to expand the wearable MedTech devices’ capabilities by fitting the analysis and measurement of various biomarkers into a compact form factor.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The technology aims to make a single wearable device that can monitor several crucial biomarkers such as blood pressure, lactate, glucose trends, body hydration, core body temperature and alcohol.

Rockley chairman and CEO Dr Andrew Rickman said: “This partnership combines Medtronic’s exceptional strength in providing in-patient care with Rockley’s expertise in wearable, remote monitoring.

“I believe that this collaboration will bring to life our vision of giving people better insights into their health and wellbeing.”             

The company stated that the collaboration with Medtronic builds on the societal shift from reactive to proactive healthcare by offering real-time, non-invasive, round-the-clock monitoring of the health and wellbeing of an individual.

This also allows clinicians to personalise healthcare with actionable data.

Recently, Medtronic introduced its NuVent Eustachian tube dilation balloon for the treatment of chronic, obstructive eustachian tube dysfunction.

The manually controlled balloon catheter system is developed to help surgeons provide treatment in an outpatient or office setting.